Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Antes

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Plos One|February 22, 2020
Systematic analysis of the binding behaviour of UHRF1 towards different methyl- and carboxylcytosine modification patterns at CpG dyadsMarkus Schneider, Carina Trummer, Andreas Stengl, et al.
Computational and Structural Biotechnology Journal|April 7, 2022
Investigation of the pH-dependent aggregation mechanisms of GCSF using low resolution protein characterization techniques and advanced molecular dynamics simulationsSuk Kyu Ko, Carolin Berner, Alina Kulakova, et al.
ACS Omega|September 9, 2021
Turning the Actin Nucleating Compound Miuraenamide into Nucleation InhibitorsShuaijun Wang, Maximilian Meixner, Lushuang Yu, et al.
Scientific Reports|May 18, 2019
A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutantsReto Eggenschwiler, Atanas Patronov, Jan Hegermann, et al.
Journal of Medicinal Chemistry|October 14, 2005
Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosisMarieke Voets, Iris Antes, Christiane Scherer, et al.
Proteins|June 12, 2016
BiPPred: Combined sequence- and structure-based prediction of peptide binding to the Hsp70 chaperone BiPMarkus Schneider, Mathias Rosam, Manuel Glaser, et al.
Journal of Medicinal Chemistry|September 4, 2008
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approachSimon Lucas, Ralf Heim, Matthias Negri, et al.
Frontiers in Chemistry|April 12, 2019
1,4-Disubstituted 1<i>H</i>-1,2,3-Triazole Containing Peptidotriazolamers: A New Class of Peptidomimetics With Interesting Foldamer PropertiesDavid C Schröder, Oliver Kracker, Tanja Fröhr, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 22, 2017
1,5-Disubstituted 1,2,3-Triazole-Containing Peptidotriazolamers: Design Principles for a Class of Versatile PeptidomimeticsOliver Kracker, Jerzy Góra, Joanna Krzciuk-Gula, et al.
Genome Biology|January 25, 2008
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virusChristoph Welsch, Francisco S Domingues, Simone Susser, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Plos One|February 22, 2020
Systematic analysis of the binding behaviour of UHRF1 towards different methyl- and carboxylcytosine modification patterns at CpG dyadsMarkus Schneider, Carina Trummer, Andreas Stengl, et al.
Computational and Structural Biotechnology Journal|April 7, 2022
Investigation of the pH-dependent aggregation mechanisms of GCSF using low resolution protein characterization techniques and advanced molecular dynamics simulationsSuk Kyu Ko, Carolin Berner, Alina Kulakova, et al.
ACS Omega|September 9, 2021
Turning the Actin Nucleating Compound Miuraenamide into Nucleation InhibitorsShuaijun Wang, Maximilian Meixner, Lushuang Yu, et al.
Scientific Reports|May 18, 2019
A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutantsReto Eggenschwiler, Atanas Patronov, Jan Hegermann, et al.
Journal of Medicinal Chemistry|October 14, 2005
Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosisMarieke Voets, Iris Antes, Christiane Scherer, et al.
Proteins|June 12, 2016
BiPPred: Combined sequence- and structure-based prediction of peptide binding to the Hsp70 chaperone BiPMarkus Schneider, Mathias Rosam, Manuel Glaser, et al.
Journal of Medicinal Chemistry|September 4, 2008
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approachSimon Lucas, Ralf Heim, Matthias Negri, et al.
Frontiers in Chemistry|April 12, 2019
1,4-Disubstituted 1<i>H</i>-1,2,3-Triazole Containing Peptidotriazolamers: A New Class of Peptidomimetics With Interesting Foldamer PropertiesDavid C Schröder, Oliver Kracker, Tanja Fröhr, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 22, 2017
1,5-Disubstituted 1,2,3-Triazole-Containing Peptidotriazolamers: Design Principles for a Class of Versatile PeptidomimeticsOliver Kracker, Jerzy Góra, Joanna Krzciuk-Gula, et al.
Genome Biology|January 25, 2008
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virusChristoph Welsch, Francisco S Domingues, Simone Susser, et al.
Pageof 7